Skip to content
Home/Companies/Biotech/AMR Bio
AMR Bio

AMR Bio

Biotech·UK·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns AMR Bio?

AMR Bio is a British Biotech company, currently owned by EMV Capital since 2025.

Hand-verified · updated 2026-07-08

Open JSON · CC-BY
EMV Capital
Investor
EMV Capital
EMV Capital Evergreen Fund · 2012 · VC

Key facts

HQUK
SectorBiotech
StatusActive
Websiteamr-bio.com

More from EMV Capital Evergreen Fund

Other portfolio companies in the same fund.

Dogtooth Technologies
Active
TMTUK· 2026
Dname-iT
Active
SoftwareUK· 2023
DeepTech Recycling
DeepTech Recycling
Active
ClimateTechUK· 2022
Ventive
Ventive
Active
IndustrialsUK· 2022
Cetromed
Active
BiotechUK· 2021
Martlet Capital
Martlet Capital
Active
FinancialsUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns AMR Bio?

AMR Bio is currently owned by EMV Capital, through EMV Capital Evergreen Fund, since 2025.

When did EMV Capital acquire AMR Bio?

EMV Capital acquired AMR Bio in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue